D47.3Billable
Essential (hemorrhagic) thrombocythemia
- Chapter
- 2. Neoplasms
- Category
- D47
- Effective date
- October 1, 2026
Related codes in category D47
D47Oth neoplm of uncrt behav of lymphoid, hematpoetc & rel tissD47.0Mast cell neoplasms of uncertain behaviorD47.01Cutaneous mastocytosisYesD47.02Systemic mastocytosisYesD47.09Other mast cell neoplasms of uncertain behaviorYesD47.1Chronic myeloproliferative diseaseYesD47.2Monoclonal gammopathyYesD47.4OsteomyelofibrosisYesD47.9Neoplm of uncrt behav of lymphoid,hematpoetc & rel tiss,unspYesD47.ZOth neoplm of uncrt behav of lymphoid, hematpoetc & rel tissD47.Z1Post-transplant lymphoproliferative disorder (PTLD)YesD47.Z2Castleman diseaseYes
Frequently asked questions
What is ICD-10 code D47.3?
D47.3 is an ICD-10-CM diagnosis code for Essential (hemorrhagic) thrombocythemia.
Is D47.3 a billable code?
Yes. D47.3 is billable and specific enough to be used on a claim.
What ICD-10-CM chapter is D47.3 in?
D47.3 falls under Chapter 2: Neoplasms.
When did D47.3 become effective?
D47.3 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to D47.3?
D47.3 belongs to category D47, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.